AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
CHANGES IN CD4(-CELL SUBSETS IN RESPONSE TO HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY IN HIV TYPE 1-INFECTED PATIENTS WITH PRIOR PROTEASE INHIBITOR EXPERIENCE() AND CD8(+) T)
Authors: GRAY CM SCHAPIRO JM WINTERS MA MERIGAN TC
Citation: Cm. Gray et al., CHANGES IN CD4(-CELL SUBSETS IN RESPONSE TO HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY IN HIV TYPE 1-INFECTED PATIENTS WITH PRIOR PROTEASE INHIBITOR EXPERIENCE() AND CD8(+) T), AIDS research and human retroviruses, 14(7), 1998, pp. 561-569
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE GENOTYPES AND IN-VITRO PROTEASE INHIBITOR SUSCEPTIBILITIES OF ISOLATES FROM INDIVIDUALS WHO WERE SWITCHED TO OTHER PROTEASE INHIBITORS AFTER LONG-TERM SAQUINAVIR TREATMENT
Authors: WINTERS MA SCHAPIRO JM LAWRENCE J MERIGAN TC
Citation: Ma. Winters et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE GENOTYPES AND IN-VITRO PROTEASE INHIBITOR SUSCEPTIBILITIES OF ISOLATES FROM INDIVIDUALS WHO WERE SWITCHED TO OTHER PROTEASE INHIBITORS AFTER LONG-TERM SAQUINAVIR TREATMENT, Journal of virology, 72(6), 1998, pp. 5303-5306
LYMPH-NODE HUMAN-IMMUNODEFICIENCY-VIRUS RNA LEVELS AND RESISTANCE MUTATIONS IN PATIENTS RECEIVING HIGH-DOSE SAQUINAVIR
Authors: SCHAPIRO JM WINTERS MA VIERRA M CRAWFORD S MERIGAN TC
Citation: Jm. Schapiro et al., LYMPH-NODE HUMAN-IMMUNODEFICIENCY-VIRUS RNA LEVELS AND RESISTANCE MUTATIONS IN PATIENTS RECEIVING HIGH-DOSE SAQUINAVIR, The Journal of infectious diseases, 177(2), 1998, pp. 477-480
A 6-BASEPAIR INSERT IN THE REVERSE-TRANSCRIPTASE GENE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CONFERS RESISTANCE TO MULTIPLE NUCLEOSIDE INHIBITORS
Authors: WINTERS MA COOLLEY KL GIRARD YA LEVEE DJ HAMDAN H SHAFER RW KATZENSTEIN DA MERIGAN TC
Citation: Ma. Winters et al., A 6-BASEPAIR INSERT IN THE REVERSE-TRANSCRIPTASE GENE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CONFERS RESISTANCE TO MULTIPLE NUCLEOSIDE INHIBITORS, The Journal of clinical investigation, 102(10), 1998, pp. 1769-1775
MULTIPLE CONCURRENT REVERSE-TRANSCRIPTASE AND PROTEASE MUTATIONS AND MULTIDRUG-RESISTANCE OF HIV-1 ISOLATES FROM HEAVILY TREATED PATIENTS
Authors: SHAFER RW WINTERS MA PALMER S MERIGAN TC
Citation: Rw. Shafer et al., MULTIPLE CONCURRENT REVERSE-TRANSCRIPTASE AND PROTEASE MUTATIONS AND MULTIDRUG-RESISTANCE OF HIV-1 ISOLATES FROM HEAVILY TREATED PATIENTS, Annals of internal medicine, 128(11), 1998, pp. 906-911
LONG-TERM AND HIGH-TEMPERATURE STORAGE OF SUPERCRITICALLY-PROCESSED MICROPARTICULATE PROTEIN POWDERS
Authors: WINTERS MA DEBENEDETTI PG CAREY J SPARKS HG SANE SU PRZYBYCIEN TM
Citation: Ma. Winters et al., LONG-TERM AND HIGH-TEMPERATURE STORAGE OF SUPERCRITICALLY-PROCESSED MICROPARTICULATE PROTEIN POWDERS, Pharmaceutical research, 14(10), 1997, pp. 1370-1378
COMPARISON OF QIAAMP HCV KIT SPIN COLUMNS, SILICA BEADS, AND PHENOL-CHLOROFORM FOR RECOVERING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA FROM PLASMA
Authors: SHAFER RW LEVEE DJ WINTERS MA RICHMOND KL HUANG D MERIGAN TC
Citation: Rw. Shafer et al., COMPARISON OF QIAAMP HCV KIT SPIN COLUMNS, SILICA BEADS, AND PHENOL-CHLOROFORM FOR RECOVERING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA FROM PLASMA, Journal of clinical microbiology, 35(2), 1997, pp. 520-522
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE GENOTYPE AND DRUG SUSCEPTIBILITY CHANGES IN INFECTED INDIVIDUALS RECEIVING DIDEOXYINOSINE MONOTHERAPY FOR 1 TO 2 YEARS
Authors: WINTERS MA SHAFER RW JELLINGER RA MAMTORA G GINGERAS T MERIGAN TC
Citation: Ma. Winters et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE GENOTYPE AND DRUG SUSCEPTIBILITY CHANGES IN INFECTED INDIVIDUALS RECEIVING DIDEOXYINOSINE MONOTHERAPY FOR 1 TO 2 YEARS, Antimicrobial agents and chemotherapy, 41(4), 1997, pp. 757-762
THE PROGNOSTIC-SIGNIFICANCE OF SERUM VIRAL LOAD, CODON-215 REVERSE-TRANSCRIPTASE MUTATION AND CD4-CELLS ON PROGRESSION OF HIV DISEASE IN A DOUBLE-BLIND-STUDY OF THYMOPENTIN( T)
Authors: MERIGAN TC HIRSCH RL FISHER AC MEYERSON LA GOLDSTEIN G WINTERS MA
Citation: Tc. Merigan et al., THE PROGNOSTIC-SIGNIFICANCE OF SERUM VIRAL LOAD, CODON-215 REVERSE-TRANSCRIPTASE MUTATION AND CD4-CELLS ON PROGRESSION OF HIV DISEASE IN A DOUBLE-BLIND-STUDY OF THYMOPENTIN( T), AIDS, 10(2), 1996, pp. 159-165
AN ASSESSMENT OF PHENOTYPIC AND GENOTYPIC CORESISTANCE TO INHIBITORS OF HIV PROTEINASE FOLLOWING THERAPY WITH HIGH-DOSE SAQUINAVIR
Authors: WHITTAKER L SCHAPIRO JM CRAIG JC WINTERS MA TOMLINSON PW SHELDON JG MOFFATT AR JACOBSEN H DUNCAN IB GILBERT S CRAWFORD S MERIGAN TC
Citation: L. Whittaker et al., AN ASSESSMENT OF PHENOTYPIC AND GENOTYPIC CORESISTANCE TO INHIBITORS OF HIV PROTEINASE FOLLOWING THERAPY WITH HIGH-DOSE SAQUINAVIR, AIDS, 10, 1996, pp. 17-17
PATIENT COMPLIANCE AND DRUG FAILURE IN PROTEASE INHIBITOR MONOTHERAPY
Authors: VANHOVE GF SCHAPIRO JM WINTERS MA MERIGAN TC BLASCHKE TF
Citation: Gf. Vanhove et al., PATIENT COMPLIANCE AND DRUG FAILURE IN PROTEASE INHIBITOR MONOTHERAPY, JAMA, the journal of the American Medical Association, 276(24), 1996, pp. 1955-1956
INTERLABORATORY COMPARISON OF SEQUENCE-SPECIFIC PCR AND LIGASE DETECTION REACTION TO DETECT A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DRUG-RESISTANCE MUTATION
Authors: SHAFER RW WINTERS MA MAYERS DL JAPOUR AJ KURITZKES DR WEISLOW OS WHITE F ERICE A SANNERUD KJ IVERSEN A PENA F DIMITROV D FRENKEL LM REICHELDERFER PS
Citation: Rw. Shafer et al., INTERLABORATORY COMPARISON OF SEQUENCE-SPECIFIC PCR AND LIGASE DETECTION REACTION TO DETECT A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DRUG-RESISTANCE MUTATION, Journal of clinical microbiology, 34(7), 1996, pp. 1849-1853
GENOTYPIC AND PHENOTYPIC CHANGES DURING CULTURE OF A MULTINUCLEOSIDE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAIN IN THE PRESENCE AND ABSENCE OF ADDITIONAL REVERSE-TRANSCRIPTASE INHIBITORS
Authors: SHAFER RW WINTERS MA IVERSEN AKN MERIGAN TC
Citation: Rw. Shafer et al., GENOTYPIC AND PHENOTYPIC CHANGES DURING CULTURE OF A MULTINUCLEOSIDE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAIN IN THE PRESENCE AND ABSENCE OF ADDITIONAL REVERSE-TRANSCRIPTASE INHIBITORS, Antimicrobial agents and chemotherapy, 40(12), 1996, pp. 2887-2890
EFFECTS OF COMPRESSED CARBON-DIOXIDE ON THE PHASE-EQUILIBRIUM AND MOLECULAR ORDER OF A LYOTROPIC POLYAMIDE SOLUTION
Authors: WINTERS MA DEBENEDETTI PG CONDO PD RADOSZ M SCHMIDT HW
Citation: Ma. Winters et al., EFFECTS OF COMPRESSED CARBON-DIOXIDE ON THE PHASE-EQUILIBRIUM AND MOLECULAR ORDER OF A LYOTROPIC POLYAMIDE SOLUTION, Macromolecules, 29(14), 1996, pp. 4904-4909
MULTIDRUG-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS RESULTING FROM COMBINATION ANTIRETROVIRAL THERAPY
Authors: IVERSEN AKN SHAFER RW WEHRLY K WINTERS MA MULLINS JI CHESEBRO B MERIGAN TC
Citation: Akn. Iversen et al., MULTIDRUG-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS RESULTING FROM COMBINATION ANTIRETROVIRAL THERAPY, Journal of virology, 70(2), 1996, pp. 1086-1090
ZIDOVUDINE RESISTANCE REVERSE-TRANSCRIPTASE MUTATIONS DURING DIDANOSINE MONOTHERAPY
Authors: SHAFER RW WINTERS MA JELLINGER RM MERIGAN TC
Citation: Rw. Shafer et al., ZIDOVUDINE RESISTANCE REVERSE-TRANSCRIPTASE MUTATIONS DURING DIDANOSINE MONOTHERAPY, The Journal of infectious diseases, 174(2), 1996, pp. 448-449
POLYETHYLENE GLYCOL-MODIFIED INTERLEUKIN-2 AND THYMOSIN ALPHA(1) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: RAMACHANDRAN R KATZENSTEIN DA WINTERS MA KUNDU SK MERIGAN TC
Citation: R. Ramachandran et al., POLYETHYLENE GLYCOL-MODIFIED INTERLEUKIN-2 AND THYMOSIN ALPHA(1) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The Journal of infectious diseases, 173(4), 1996, pp. 1005-1008
THE ASSOCIATION BETWEEN HIV PHENOTYPE, VIRUS BURDEN, CODON-215 MUTATION AND CD4 CELL DECLINE - REPLY
Authors: KOZAL MJ SHAFER RW WINTERS MA KATZENSTEIN DA HALPERN J MERIGAN TC
Citation: Mj. Kozal et al., THE ASSOCIATION BETWEEN HIV PHENOTYPE, VIRUS BURDEN, CODON-215 MUTATION AND CD4 CELL DECLINE - REPLY, Journal of acquired immune deficiency syndromes and human retrovirology, 9(1), 1995, pp. 101-102
DRUG-RESISTANCE AND HETEROGENEOUS LONG-TERM VIROLOGICAL RESPONSES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED SUBJECTS TO ZIDOVUDINE AND DIDANOSINE COMBINATION THERAPY
Authors: SHAFER RW IVERSEN AKN WINTERS MA AGUINIGA E KATZENSTEIN DA MERIGAN TC
Citation: Rw. Shafer et al., DRUG-RESISTANCE AND HETEROGENEOUS LONG-TERM VIROLOGICAL RESPONSES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED SUBJECTS TO ZIDOVUDINE AND DIDANOSINE COMBINATION THERAPY, The Journal of infectious diseases, 172(1), 1995, pp. 70-78
CLARIFICATION OF A METHOD TO REVERSE TRANSCRIBE HUMAN-IMMUNODEFICIENCY-VIRUS RNA
Authors: KOZAL MJ SHAFER RW WINTERS MA KATZENSTEIN DA MERIGAN TC
Citation: Mj. Kozal et al., CLARIFICATION OF A METHOD TO REVERSE TRANSCRIBE HUMAN-IMMUNODEFICIENCY-VIRUS RNA, The Journal of infectious diseases, 171(4), 1995, pp. 1072-1072
HIV-1 SYNCYTIUM-INDUCING PHENOTYPE, VIRUS BURDEN CODON-215 REVERSE-TRANSCRIPTASE MUTATION AND CD4 CELL DECLINE IN ZIDOVUDINE-TREATED PATIENTS
Authors: KOZAL MJ SHAFER RW WINTERS MA KATZENSTEIN DA AGUINIGA E HALPERN J MERIGAN TC
Citation: Mj. Kozal et al., HIV-1 SYNCYTIUM-INDUCING PHENOTYPE, VIRUS BURDEN CODON-215 REVERSE-TRANSCRIPTASE MUTATION AND CD4 CELL DECLINE IN ZIDOVUDINE-TREATED PATIENTS, Journal of acquired immune deficiency syndromes, 7(8), 1994, pp. 832-838
DETECTION OF DRUG-RESISTANCE MUTATIONS IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) POL GENE - DIFFERENCES IN SEMEN AND BLOOD HIV-1 RNA AND PROVIRAL DNA
Authors: KROODSMA KL KOZAL MJ HAMED KA WINTERS MA MERIGAN TC
Citation: Kl. Kroodsma et al., DETECTION OF DRUG-RESISTANCE MUTATIONS IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) POL GENE - DIFFERENCES IN SEMEN AND BLOOD HIV-1 RNA AND PROVIRAL DNA, The Journal of infectious diseases, 170(5), 1994, pp. 1292-1295
MULTICENTER EVALUATION OF QUANTIFICATION METHODS FOR PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA
Authors: LIN HJ MYERS LE YENLIEBERMAN B HOLLINGER FB HENRARD D HOOPER CJ KOKKA R KWOK S RASHEED S VAHEY M WINTERS MA MCQUAY LJ NARA PL REICHELDERFER P COOMBS RW JACKSON JB
Citation: Hj. Lin et al., MULTICENTER EVALUATION OF QUANTIFICATION METHODS FOR PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA, The Journal of infectious diseases, 170(3), 1994, pp. 553-562
COMBINATION THERAPY WITH ZIDOVUDINE AND DIDANOSINE SELECTS FOR DRUG-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS WITH UNIQUE PATTERNS OF POL GENE-MUTATIONS
Authors: SHAFER RW KOZAL MJ WINTERS MA IVERSEN AKN KATZENSTEIN DA RAGNI MV MEYER WA GUPTA P RASHEED S COOMBS R KATZMAN M FISCUS S MERIGAN TC
Citation: Rw. Shafer et al., COMBINATION THERAPY WITH ZIDOVUDINE AND DIDANOSINE SELECTS FOR DRUG-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS WITH UNIQUE PATTERNS OF POL GENE-MUTATIONS, The Journal of infectious diseases, 169(4), 1994, pp. 722-729
DIDANOSINE RESISTANCE IN HIV-INFECTED PATIENTS SWITCHED FROM ZIDOVUDINE TO DIDANOSINE MONOTHERAPY
Authors: KOZAL MJ KROODSMA K WINTERS MA SHAFER RW EFRON B KATZENSTEIN DA MERIGAN TC
Citation: Mj. Kozal et al., DIDANOSINE RESISTANCE IN HIV-INFECTED PATIENTS SWITCHED FROM ZIDOVUDINE TO DIDANOSINE MONOTHERAPY, Annals of internal medicine, 121(4), 1994, pp. 263-268
Risultati: 1-25 | 26-28